TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer

Title
TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 12, Issue 8, Pages 1676-1687
Publisher
American Association for Cancer Research (AACR)
Online
2013-05-30
DOI
10.1158/1535-7163.mct-12-1019

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started